Joseph Hernandez - Dec 12, 2021 Form 4 Insider Report for Clarus Therapeutics Holdings, Inc. (CRXT)

Role
Director
Signature
/s/ Steven A. Bourne, attorney-in-fact
Stock symbol
CRXT
Transactions as of
Dec 12, 2021
Transactions value $
$0
Form type
4
Date filed
12/14/2021, 06:00 PM
Previous filing
Sep 13, 2021
Next filing
Feb 17, 2022

Transactions Table

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Ownership Footnotes
transaction CRXT Common Stock Award $0 +3.84K $0.00 3.84K Dec 12, 2021 Direct F1
holding CRXT Common Stock 1.3M Dec 12, 2021 See Footnote F2

Derivative Securities (e.g., puts, calls, warrants, options, convertible securities)

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Underlying Class Amount Exercise Price Ownership Footnotes
transaction CRXT Stock Option (Right to Buy) Award $0 +9.61K $0.00 9.61K Dec 12, 2021 Common Stock 9.61K $4.78 Direct F3
* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id Content
F1 The Reporting Person was granted a Restricted Stock Unit under the Issuer's 2021 Stock Option and Incentive Plan (the "2021 Plan") for 3,844 shares on 12/12/2021, which vests in equal annual installments over three years from the date of grant subject to the Reporting Person having a service relationship as of each such vesting date.
F2 Mr. Joseph Hernandez, a director and former chief executive officer of the Issuer, is the managing member of the Blue Water Sponsor LLC (the "Sponsor"). Accordingly, Mr. Hernandez may be deemed to have beneficial ownership of such shares. Mr. Hernandez disclaims any beneficial ownership of the reported shares other than to the extent of any pecuniary interest he may have therein, directly or indirectly.
F3 These options were granted under the 2021 Plan and vest in equal annual installments over a period of three years from the date of grant subject to the Reporting Person having a service relationship as of each such vesting.